Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis.
Ontology highlight
ABSTRACT: Somatic mutations are one of the most important factors in tumorigenesis and are the focus of most cancer-sequencing efforts. The co-occurrence of multiple mutations in one tumor has gained increasing attention as a means of identifying cooperating mutations or pathways that contribute to cancer. Using multi-omics, phenotypical, and clinical data from 29,559 cancer subjects and 1747 cancer cell lines covering 78 distinct cancer types, we show that co-mutations are associated with prognosis, drug sensitivity, and disparities in sex, age, and race. Some co-mutation combinations displayed stronger effects than their corresponding single mutations. For example, co-mutation TP53:KRAS in pancreatic adenocarcinoma is significantly associated with disease specific survival (hazard ratio = 2.87, ad
SUBMITTER: Jiang L
PROVIDER: S-EPMC8774165 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA